跳至主要内容
临床试验/CTRI/2023/01/048812
CTRI/2023/01/048812招募中不适用

Study of The effect of Desmopressin in Reducing Post Kidney Biopsy Bleeding Complications in Patients with Reduced Renal Function

AIIMS JODHPUR1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2023年9月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
AIIMS JODHPUR
入组人数
150
试验地点
1
主要终点
INCIDENCE OF POST KIDNEY BIOPSY BLEEDING COMPLICATION (perirenal hematoma, gross hematuria, AV fistula formation, Blood transfusion, arterial embolization or death)

研究概览

简要总结

Desmopressin has been used to decreased the post biopsy bleeding complication. One RCT in patient with normal renal function has shown that desmopressin had reduced post kidney biopsy bleeding complication in normal functioning kidney. However, there is no prospective trial of desmopression on patient with reduced renal function. Hence we design this study to study the impact of desmopressin in reducing bleeding complication post kidney biopsy in patients with reduced renal function.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Participant and Investigator Blinded

入排标准

年龄范围
18.00 Year(s) 至 80.00 Year(s)(—)
性别
All

入选标准

  • •eGFR LESS THAN OR EQUAL TO 60ML/MIN PLATELET COUNT >1LACK NORMAL COAGULATION PROFILE BP<140/90.

排除标准

  • •SOLITARY KIDNEY RENAL CELL CARCINOMA HYDRO/PYONEPHROSIS CONTRATED KIDNEY BILATERAL MORBID OBESITY >40KG/M2 POST RENAL TRANSPLANT SEVERSE NASAL CONGESTION,BLOCKAGE,ATROPHIC RHINITIS SERUM SODIUM<125mEq/L.

结局指标

主要结局

INCIDENCE OF POST KIDNEY BIOPSY BLEEDING COMPLICATION (perirenal hematoma, gross hematuria, AV fistula formation, Blood transfusion, arterial embolization or death)

时间窗: at 6 hrs and 24 hrs post biopsy

次要结局

  • PREDICTOR OF BLEEDING COMPLICATION(AT 24 HR POST PROCEDURE)

研究者

发起方
AIIMS JODHPUR
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验